{
  "image_filename": "figure_p3_det_2_001.png",
  "image_path": "Arunachalam_et_al.__2021_/extracted/figures/figure_p3_det_2_001.png",
  "image_type": "Figure",
  "page_number": 3,
  "block_id": "det_2_001",
  "claim_id": "claim_003",
  "claim": "Recombinant technology leads to a broader immune response that may provide cross-protection, even in a mismatch season.",
  "supports_claim": false,
  "explanation": "A schematic flow diagram showing the baculovirus\u2013insect cell expression system for manufacturing recombinant HA (RIV4) vaccine: includes cloning of HA gene into baculovirus vector under polyhedrin promoter, infection of insect cells, bioreactor expansion, harvest, extraction, clarification, capture, purification (including DNA removal), and formulation steps. does not support the claim because the figure only outlines the manufacturing process of a recombinant HA vaccine and contains no data or information on immune response breadth, cross-protection, or mismatch-season efficacy.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "A schematic flow diagram showing the baculovirus\u2013insect cell expression system for manufacturing recombinant HA (RIV4) vaccine: includes cloning of HA gene into baculovirus vector under polyhedrin promoter, infection of insect cells, bioreactor expansion, harvest, extraction, clarification, capture, purification (including DNA removal), and formulation steps.",
    "evidence_found": null,
    "reasoning": "does not support the claim because the figure only outlines the manufacturing process of a recombinant HA vaccine and contains no data or information on immune response breadth, cross-protection, or mismatch-season efficacy.",
    "confidence_notes": null
  }
}